(Q39412652)

11 September 2017

title

Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain (English)

1 reference

11 September 2017

0 references

Lennard P Niles

1

1 reference

11 September 2017

Arani Sathiyapalan

2

1 reference

11 September 2017

Sarra Bahna

3

1 reference

11 September 2017

Na Hyea Kang

4

1 reference

11 September 2017

Yi Pan

5

1 reference

11 September 2017

publication date

16 January 2012

1 reference

The International Journal of Neuropsychopharmacology

11 September 2017

published in

1 reference

11 September 2017

volume

15

1 reference

11 September 2017

issue

9

1 reference

11 September 2017

page(s)

1343-1350

1 reference

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Neurogenesis and affective disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Dose-dependent memory effects and cerebral volume changes after in utero exposure to valproate in the rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

A neurotrophic model for stress-related mood disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Depression: a case of neuronal life and death?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Gene structures, biochemical characterization and distribution of rat melatonin receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Role of melatonin receptors in the effects of melatonin on BDNF and neuroprotection in mouse cerebellar neurons

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Novel melatonin-based therapies: potential advances in the treatment of major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Multiple astrocyte transcripts encode nigral trophic factors in rat and human

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711001969

7 January 2021

10.1017/S1461145711001969

Identifiers

DOI

1 reference

11 September 2017

1 reference